Orlance, Inc.

About Orlance, Inc.

Orlance aims to deliver powdered, needle-free, shelf-stable nucleic acid vaccines (DNA and/or RNA) using its epidermal vaccine delivery platform, focusing on eliminating cold chain requirements and enhancing vaccine accessibility.

Products & Services

Orlance MACH-1 ™:A low-dose, needle-free powdered nucleic acid vaccine delivery system that does not require cold chain storage.

Specialties

Needle-free vaccine delivery Powdered nucleic acid vaccines (DNA and RNA) Epidermal vaccine delivery platform Shelf-stable vaccine technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: NIH Fast Track Small Business Innovation Research (SBIR) Grant T: - FT: NIH Fast Track Small Business Innovation Research (SBIR) Grant	A: 3300000 MR: - FA: $3.3 million FAN: 3300000	D: 2024-10-10 FD: 2024-10-10	1 investors
2	RT: Phase I Small Business Innovation Research (SBIR) Grant T: - FT: Phase I Small Business Innovation Research (SBIR) Grant	A: 600000 MR: - FA: $600,000 FAN: 600000	D: 2024-07-10 FD: 2024-07-10	1 investors
3	RT: NIH SBIR Grant (Phase II) T: - FT: NIH SBIR Grant (Phase II)	A: 3000000 MR: - FA: $3M FAN: 3000000	D: 2023-11-28 FD: 2023-11-28	1 investors
4	RT: NIH SBIR Grant (Phase I) T: - FT: NIH SBIR Grant (Phase I)	A: 12900000 MR: - FA: $12.9M (cumulative SBIR funding total) FAN: 12900000	D: 2023-11-28 FD: 2023-11-28	2 investors

NIH Fast Track Small Business Innovation Research (SBIR) Grant Latest

2024-10-10

$3.3M

1 investor (Pro only)

Phase I Small Business Innovation Research (SBIR) Grant 2024-07-10

$600K

NIH SBIR Grant (Phase II) 2023-11-28

$3.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

KRIS AALTO

CEO

D

DEB FULLER

CTO

K

KEN BAGLEY

Director R&D

H

HANNAH FRIZZELL

Program Director, Preclinical Development

L

LYUDA LEBEDINSKI

Senior Administrative and Financial Manager

C

Chris Press

Senior Research Technician

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Orlance, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised